OKYO Pharma (OKYO Pharma) FCF Yield % : -15.98 (As of May. 22, 2024)

View and export this data going back to 2022. Start your Free Trial

What is OKYO Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, OKYO Pharma's Trailing 12-Month Free Cash Flow is $-7.70 Mil, and Market Cap is $48.19 Mil. Therefore, OKYO Pharma's FCF Yield % for today is -15.98%.

The historical rank and industry rank for OKYO Pharma's FCF Yield % or its related term are showing as below:

OKYO' s FCF Yield % Range Over the Past 10 Years
Min: -19.15 Med: 0 Max: 0
Current: -15.98

OKYO's FCF Yield % is ranked worse than
52.96% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs OKYO: -15.98

OKYO Pharma's FCF Margin % for the quarter that ended in Mar. 2023 was 0.00%.

OKYO Pharma FCF Yield % Historical Data

The historical data trend for OKYO Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma FCF Yield % Chart

OKYO Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Yield %

Get a 7-Day Free Trial

-8.98

OKYO Pharma Semi-Annual Data
	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-11.34	-10.39

Competitive Comparison of OKYO Pharma's FCF Yield %

For the Biotechnology subindustry, OKYO Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OKYO Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's FCF Yield % falls into.

OKYO Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

OKYO Pharma's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-7.701	/	85.746864
	=	-8.98%

OKYO Pharma's annualized FCF Yield % for the quarter that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-4.456	*	2	/	85.746864
	=	-10.39%

OKYO Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

OKYO Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of OKYO Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

OKYO Pharma (OKYO Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (NAS:OKYO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

OK10:Germany

Address

14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ

Website

https://www.okyopharma.com

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Executives

John P Brancaccio	director	C/O TAMIR BIOTECHNOLOGY, INC., 11 DEER PARK DRIVE, SUITE 204, MONMOUTH JUNCTION NJ 08852
Gary S Jacob	director, officer: Chief Executive Officer
Gabriele M Cerrone	director, 10 percent owner, officer: Executive Chairman	265 EAST 66TH STREET, SUITE 16G, NEW YORK NY 10021
Bernard Denoyer	director	C/O CALLISTO PHARMACEUTICALS, INC., 420 LEXINGTON AVENUE, SUITE 1609, NEW YORK NY 10170
Willy Jules Simon	director	PLAYLOGIC INTERNATIONAL NV, CONCERTGEBOUWPLEIN 13, AMSTERDAM P7 1071 LL
Keeren Shah	officer: Chief Financial Officer	55 PARK LANE, LONDON X0 W1K 1NA